Washington SB 6127: Increasing access to human immunodeficiency virus postexposure prophylaxis drugs or therapies.

Status: Effective date 1/1/2025. (as of 2024-03-25)

State: Washington · Session: 2023-2024 · Bill: SB 6127

Sponsors: Liias, Frame, Hasegawa, Kuderer, Lovick, Muzzall, Nobles, Pedersen, Randall, Rivers

View Washington SB 6127 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.